<p>[단독 제보] <br>보로노이 파트너사 Fresh Tracks(FRTX US)가 아토피/알츠하이머 치료제로 개발중인 DYRK1A FRTX-02(VRN-02)의 단일상승용량(SAD), 다중상승용량(MAD) 1상 싱험에서 긍정적인 탑라인 결과 발표.  <br>보로노이 파트너 FRTX after 주가 +68% 폭등 <br>*** 보로노이 (310210) <br><br>FRTX 시가총액은 $5.5mn 원화 72억원 수준 <br><a href="https://ir.frtx.com/news/detail/95/fresh-tracks-therapeutics-announces-positive-topline" target="_blank" class="ke-link">https://ir.frtx.com/news/detail/95/fresh-tracks-therapeutics-announces-positive-topline</a><br><br><br></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="Fresh Tracks Therapeutics Announces Positive Topline Results from Single and Multiple Ascending Dose Parts of Phase 1 Study of O" data-og-description="FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the study’s primary objectives …..." data-og-host="ir.frtx.com" data-og-source-url="https://ir.frtx.com/news/detail/95/fresh-tracks-therapeutics-announces-positive-topline" data-og-url="https://ir.frtx.com/news/detail/95/fresh-tracks-therapeutics-announces-positive-topline" data-og-image="https://scrap.kakaocdn.net/dn/i8gog/hyRRD6e48G/FCm5ckl9KyURrZrUiNtLK1/img.jpg?width=1200&height=627&face=0_0_1200_627"><a href="https://ir.frtx.com/news/detail/95/fresh-tracks-therapeutics-announces-positive-topline" target="_blank" data-source-url="https://ir.frtx.com/news/detail/95/fresh-tracks-therapeutics-announces-positive-topline"><div class="og-image" style="background-image:url(https://scrap.kakaocdn.net/dn/i8gog/hyRRD6e48G/FCm5ckl9KyURrZrUiNtLK1/img.jpg?width=1200&height=627&face=0_0_1200_627)"></div><div class="og-text"><p class="og-title">Fresh Tracks Therapeutics Announces Positive Topline Results from Single and Multiple Ascending Dose Parts of Phase 1 Study of O</p><p class="og-desc">FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the study’s primary objectives …...</p><p class="og-host">ir.frtx.com</p></div></a></div><p> </p><p><span data-ke-size="size14">*** 본 정보는 투자 참고용 자료로서 그 정확성이나 완전성을 보장할 수 없으며, 어떠한 경우에도 법적 책임소재에 대한 증빙자료로 사용될 수 없습니다.</span></p><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%; height: 75px;" border="1" data-ke-style="style13"><tbody><tr style="height: 75px;"><td style="width: 756px; height: 75px; text-align: center;"><a href="https://cafe.daum.net/stockwang/As9F/3070" target="_blank" class="ke-link"><span style="color: #ee2323;" data-ke-size="size26"><b>'돈' 잃지 마라! '돈'을 지켜라! 그리고 '돈'을 불려라!</b></span></a></td></tr></tbody></table></div><p> </p>
<!-- -->
